Biotech · Private company
Neurelis, Inc.
Track this companyFree. Adds Neurelis, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials30 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NRL-1Phase 3 · Acute Repetitive SeizuresClinicalTrials.gov · fetched Nov 12, 2026
- Diazepam Nasal Spray [Valtoco]Phase 2 · EpilepsyClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Pharmacokinetics Study of VALTOCO® in Pediatric Subjects With EpilepsyPHASE1_PHASE2 · COMPLETED · started Nov 8, 2021ClinicalTrials.gov NCT05076838 · fetched Nov 12, 2026
- Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy SubjectsPHASE1 · COMPLETED · started Jun 30, 2016ClinicalTrials.gov NCT02724423 · fetched Nov 12, 2026
- Repeat Dose Safety Study of NRL-1 in Epilepsy SubjectsPHASE3 · COMPLETED · started Apr 11, 2016ClinicalTrials.gov NCT02721069 · fetched Nov 12, 2026